Biosurveillance Market Size, Share And Industry Analysis , And Region, Segment Forecasts To 2030

Description

The global Biosurveillance Market is forecasted to grow at a rate of 5.0% from USD 3.80 Billion in 2019 to USD 5.62 Billion in 2030. The recent H1N1 Influenza outbreak, SARS outbreak, and anthrax attacks in 2001 have made the government of various nations realize the importance of surveillance methods as an essential element of preparedness for bioterrorism.

The increasing demand for the service can be clearly established with the help of the fact that after the terrorist attack and release of anthrax in 2001, in just the US, USD 32 Billion have been allocated to biosurveillance & biodefense.             

The global biosurveillance system has also been significantly impacted by advancements in information science and IoT that have resulted in enhancing the effectiveness and efficiency of public health surveillance. The mentioned developments have resulted in changing the way of processing, collecting, decision making, learning, and analyzing data for research. This service is also witnessing growing popularity among health departments to monitor conditions that have a lack of surveillance systems like carbon monoxide poisonings and disseminate this information for enhancing public health situational awareness.  

Though various supporting factors are fostering market growth, adverse factors like lack of required infrastructure in developing nations, and limited studies on the practice of bioterrorism surveillance may negatively impact the growth of the market. Other complications like lack of interoperability and limited coordination among the various private and government surveillance systems may also negatively impact the effectiveness of the system. There are concerns associated with infringement on the privacy of users, which would also negatively impact market growth.

Biosurveillance tools are used by the department of homeland security very extensively in the U.S. to monitor the situation in the country. BioWatch is the U.S. government program to discover biological agents present in the environment.

Type Outlook:

The Syndromic Surveillance segment held a significant share of more than 40.0% in 2019. The market share held by the Syndromic Surveillance segment is attributed to its wide application and demand from the public health sector. In identifying a bioterrorism event, it plays a pivotal role in maintaining a strong index of suspicion. The data associated with such surveillance are gathered prior to the report of laboratory results. Due to the above-mentioned advantage, the surveillance turns out to be effective for health departments to identify incidents of increased disease incidence rate prior to formal diagnosis and respond to outbreaks like COVID-19 in an effective manner. Methods of conducting such surveillance may comprise data points and clues that may be used by public health personnel for recognizing patterns. Data sources like chief complaints from emergency-department visits, over-the-counter medication purchases, and nurse hotline calls are effective ways of monitoring illness clusters. High investment in this type of surveillance can be seen to be made by the US Government, military, the CDC, local & state public health agencies.

Technology and Equipment Outlook:

In context to Technology & Equipment, the Detection technology & equipment segment held a considerable share of the market of more than 45.0% in 2019. Some of the mentionable detection technology & equipment are the Joint Biological Agent Identification and Diagnostic System (JBAIDS), Autonomous Pathogen Detection System, Biological Materials MASINTCell, CANARY, among others. The market share held by the Detection technology & equipment segment is attributed to the fact that the main emphasis of this surveillance is on early detection of health events and detection of disease outbreak, which makes this technology and equipment the primary need for conducting the surveillance. In the process of conducting biosurveillance, the first step of the process is detection, which clearly establishes the importance of this technology and equipment.  

Applications Outlook:

The Human and animal populations segment held a considerable share of the market of more than 40.0% in 2019. The market share held by the Human and animal populations segment is attributed to the fact that major disease outbreak like COVID-19 or biological attacks like anthrax attacks have a direct impact on the human population, which makes the application of the surveillance on human population essential to control such outbreaks. In certain cases, the outbreak of these diseases can also be seen to have impacted animals, like few cases of tigers being infected by COVID-19 have been reported across the globe, which also contributes to the market share held by this segment.

Regional Outlook:

North America can be seen to dominate the market that held more than 35.0% of the market in 2019. The market dominance of the region is attributed to its technological advancements and high incidence rate & impact of infectious diseases in this region, which is supporting the expansion of the market in this region. Furthermore, a high rate of investment on this sector by the government of this region, wherein after the terrorist attack and release of anthrax in 2001, in just the US, USD 32 Billion have been allocated to biosurveillance & biodefense is also boosting the growth of the market in this region. The COVID-19 pandemic has also taken a major toll on North America wherein in the U.S. as of 4 May 2020, there were 1,191,849 cases, which would also result in increasing the demand for such surveillance in the coming time that would also have a positive impact on the growth of the sector in this region.

Market-O-Nomics

  • In recent years, biosurveillance services have gained significance as never before.  It has been particularly observed after 2001, followed by the terrorist attack and anthrax release.
  • The Medical intelligence segment is projected to witness a considerable growth rate of 6.0% during the forecast period. The growth rate witnessed by the Medical intelligence segment is attributed to continuous expansion of medical intelligence and the essential role played by such surveillance in reliably, securely and rapidly synthesize, share and collect different information sources in the medical intelligence sector.
  • The detection technology & equipment segment held a considerable share in 2019. This is attributed to the fact that the main emphasis of this surveillance is on early detection of health events and detection of disease outbreak, which makes this technology and equipment the primary need for conducting the surveillance.
  • Biosurveillance is considered as a way of releasing the lockdown and managing the risk of the second wave of outbreak. It is with the help of the surveillance, and governments can ascertain that individuals who may have or have the virus remain isolated. To ascertain it, conditioning the behavior and monitoring of the entire population is essential, which can be done with the help of such surveillance that would result in fostering the growth of the market.

Companies considered and profiled in this market study

Bitscopic, Hawkeye Systems, Inc., NanoViricides, Inc., Co-Diagnostics, Inc., Gilead Sciences, Inc., Novavax, Inc., Dynport Vaccine Company LLC, B.Ichor Medical Systems, Bavarian Nordic and Cleveland Biolabs, has been profiled in the report. They are the major manufacturers of the product.

The players operating in the market have undertaken a number of strategies related to the market in the period 2017-2020. The key highlight is:

  • In December 2018, ADA-Space and the University of Electronic Science and Technology of China (UESTC) in collaboration had launched a second-generation AI satellite, TFSTAR. This satellite is effective in processing and analytics that enables it to sift through the data. By integrating data processing capability of TFSTAR with geocoding, a COVID-19 health visualization was created on which individuals are able to see the geographic reach of the infection and could identify the active infection and distance between them.
  • In 2020, the Chinese government joined hands with tech giants Tencent and Alibaba for developing a color-coded health rating system that is applicable for tracking millions of people daily. Such collaboration and the launch of new products would positively impact the growth of the market.

Start-up Traction

The industry offers numerous growth opportunities. Thus, a number of startups providing innovative products and technologies have been entering the market. Some of them include Electronic Health Network, and Bitscopic, among others.

Electronic Health Network has developed a data platform, MiNT, that is a tech enabler for nations that are looking forward to applying digital upgrades for everything from provider payment processes, population health research efforts, and care delivery. The app is also applicable as the foundation network supporting web-based platforms that coordinate biosurveillance apps, ambulances, call centers, and first responders.  

Deals Landscape

Mergers and Acquisitions are an integral part of the Artificial Intelligence (AI) as a Service industry. Along with the companies operating in the market, other key market players have also been entering the industry.

  • In February 2020, Hawkeye Systems, Inc., one of the mentionable market players have signed LOI with Major n95 Mask distributer in Taiwan. The focus of this LOI was the rapid production of Smart Masks for Bio-surveillance Response to COVID-19 Outbreak. The smart mask would collaborate with the jointly developed in-depth camera of Hawkeye to support bio-surveillance by first responders and others managing and monitoring the global 19 crisis.

Expert Insights:

Reports and Data forecast promising developments for increased adoption of Biosurveillance, which would be particularly observable in the first three quarters of 2020. In the opinion of industry experts, the COVID-19 outbreak has resulted in highlighting the importance of electronically reported data for easily integrating and analyzing patterns indicating the nature of the outbreak, whether it is occurring naturally or it is a bio-terrorism caused infection. It would result in positively impacting the growth of the sector. The early trend detection can be shared with clinicians and other essential segments of the healthcare sector that can turn out to be effective in formulating a holistic treatment and management process of the infection.

Segments Covered in the report

This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2017 to 2027. The scope of the report can be defined as:

For the purpose of this report, Reports and Data have segmented the global Biosurveillance market on the basis of type, technology & equipment, end-user, application, end-use, and region:

Type Outlook (Revenue, USD Billion; 2019-2030)

  • Syndromic Surveillance
  • Alternative Surveillance Systems
  • Laboratory Surveillance
  • Environmental Surveillance

Technology and Equipment Outlook (Revenue, USD Billion; 2019-2030)

  • Biocontainment technology & equipment
  • Detection technology & equipment
  • Protection technology & equipment

Application Outlook (Revenue, USD Billion; 2019-2030)

  • Human and animal populations
  • Water
  • Food
  • Agriculture
  • Environment

End-Use Outlook (Revenue, USD Billion; 2019-2030)

  • Human and animal populations
  • Water
  • Food
  • Agriculture
  • Environment

End-User Outlook (Revenue, USD Billion; 2019-2030)

  • Government administrative bodies
  • Research organizations
  • Healthcare organization and laboratory
  • Government contractors
  • Academic centers and think tanks

Regional Outlook (Revenue, USD Billion; 2019-2030)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • MEA
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENT

Chapter 1. Market Synopsis
    1.1. Market Definition
    1.2. Research Scope & Premise
    1.3. Methodology
    1.4. Market Estimation Technology
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2030
Chapter 3. Indicative Metrics
Chapter 4. Biosurveillance Market Segmentation & Impact Analysis
    4.1. Biosurveillance Market Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
                  4.2.2.1. The increasing occurrence rate of infectious diseases
                  4.2.2.2. The rising emphasis of governments of different nations on strengthening biodefense
                  4.2.2.3. COVID-19 pandemic
          4.2.3. Market restraints analysis
                  4.2.3.1. Lack of required infrastructure in developing nations
                 4.2.3.2. Limited studies on practice of bioterrorism surveillance
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. ETOP Analysis
    4.6. Porter’s Five Forces Analysis
    4.7. Competitive Metric Space Analysis
    4.8. Price Trend Analysis
    4.9. Customer Mapping
    4.10. Covid-19 Impact Analysis
    4.11. Global Recession Influence
Chapter 5. Biosurveillance Market By Type Insights & Trends
    5.1. Type Dynamics & Market Share, 2019 & 2030
    5.2. Syndromic Surveillance
          5.2.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          5.2.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    5.3. Alternative Surveillance Systems
          5.3.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          5.3.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    5.4. Laboratory Surveillance
          5.4.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          5.4.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    5.5. Environmental Surveillance
          5.5.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          5.5.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
Chapter 6. Biosurveillance Market By Technology & equipment Insights & Trends
   6.1. Technology & equipment Dynamics & Market Share, 2019 & 2030
   6.2. Biocontainment technology & equipment
          6.2.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          6.2.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    6.3. Detection technology & equipment
          6.3.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          6.3.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
   6.4. Protection technology & equipment
          6.4.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          6.4.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
Chapter 7. Biosurveillance Market By Application Insights & Trends
    7.1. Application Dynamics & Market Share, 2019 & 2030
    7.2. Human and animal populations
          7.2.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          7.2.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    7.3. Water
          7.3.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          7.3.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    7.4. Food
          7.4.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          7.4.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    7.5. Agriculture
           7.5.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
           7.5.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    7.6. Environment
          7.6.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          7.6.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
Chapter 8. Biosurveillance Market By End-use Insights & Trends
    8.1. End-use Dynamics & Market Share, 2019 & 2030
    8.2. Biosurveillance
          8.2.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          8.2.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    8.3. Threat reduction
           8.3.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
           8.3.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    8.4. Biosecurity
           8.4.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
           8.4.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    8.5. Disaster response
          8.5.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          8.5.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    8.6. Medical intelligence
          8.6.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          8.6.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
Chapter 9. Biosurveillance Market By End-user Insights & Trends
    9.1. End-user Dynamics & Market Share, 2019 & 2030
    9.2. Government administrative bodies
          9.2.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          9.2.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    9.3. Research organizations
          9.3.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
          9.3.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    9.4. Healthcare organization and laboratory
           9.4.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
           9.4.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    9.5. Government contractors
           9.5.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
           9.5.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
    9.6. Academic centers and think tanks
           9.6.1. Market estimates and forecast, 2019 – 2030 (USD Billion)
           9.6.2. Market estimates and forecast, By Region, 2019 – 2030 (USD Billion)
Chapter 10. Biosurveillance Market Regional Outlook
    10.1. Biosurveillance Market share By Region, 2019 & 2030
    10.2. North America
           10.2.1. Covid-19 Impact Analysis, 2020-2021
           10.2.2. Global Recession Influence, 2020-2021
           10.2.3. North America Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
           10.2.4. North America Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
           10.2.5. North America Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
           10.2.6. North America Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
           10.2.7. North America Biosurveillance Market estimates and forecast By End-use, 2019 –2030, (USD Billion)
           10.2.8. North America Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
           10.2.9. U.S.
                     10.2.9.1. U.S. Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
                     10.2.9.2. U.S. Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
                     10.2.9.3. U.S. Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
                     10.2.9.4. U.S. Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
                     10.2.9.5. U.S. Biosurveillance Market estimates and forecast By End-use, 2019 –2030, (USD Billion)
                    10.2.9.6. U.S. Biosurveillance Market estimates and forecast By End-user, 2019 –2030, (USD Billion)
    10.3. Europe
            10.3.1. Covid-19 Impact Analysis, 2020-2021
            10.3.2. Global Recession Influence, 2020-2021
            10.3.3. Europe Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
            10.3.4. Europe Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
            10.3.5. Europe Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
            10.3.6. Europe Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
            10.3.7. Europe Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
            10.3.8. Europe Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
             10.3.9. U.K.
                        10.3.9.1. U.K. Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
                        10.3.9.2. U.K. Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
                        10.3.9.3. U.K. Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
                        10.3.9.4. U.K. Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
                        10.3.9.5. U.K. Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
                        10.3.9.6. U.K. Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
             10.3.10. France
                         10.3.10.1. France Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
                         10.3.10.2. France Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
                         10.3.10.3. France Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
                         10.3.10.4. France Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
                         10.3.10.5. France Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
                         10.3.10.6. France Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
    10.4. Asia-Pacific
             10.4.1. Covid-19 Impact Analysis, 2020-2021
             10.4.2. Global Recession Influence, 2020-2021
             10.4.3. Asia Pacific Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
             10.4.4. Asia Pacific Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
             10.4.5. Asia Pacific Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
             10.4.6. Asia Pacific Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
             10.4.7. Asia Pacific Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
             10.4.8. Asia Pacific Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
             10.4.9. China
                        10.4.9.1. China Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
                        10.4.9.2. China Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
                        10.4.9.3. China Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
                        10.4.9.4. China Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
                        10.4.9.5. China Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
                        10.4.9.6. China Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
             10.4.10. India
                          10.4.10.1. India Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
                          10.4.10.2. India Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
                          10.4.10.3. India Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
                          10.4.10.4. India Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
                          10.4.10.5. India Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
                          10.4.10.6. India Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
              10.4.11. Japan
                          10.4.11.1. Japan Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
                          10.4.11.2. Japan Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
                          10.4.11.3. Japan Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
                          10.4.11.4. Japan Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
                          10.4.11.5. Japan Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
                          10.4.11.6. Japan Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
    10.5. Middle East and Africa
            10.5.1. Covid-19 Impact Analysis, 2020-2021
            10.5.2. Global Recession Influence, 2020-2021
            10.5.3. Middle East and Africa Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
            10.5.4. Middle East and Africa Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
            10.5.5. Middle East and Africa Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
            10.5.6. Middle East and Africa Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
            10.5.7. Middle East and Africa Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
            10.5.8. Middle East and Africa Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
    10.6. Latin America
             10.6.1. Covid-19 Impact Analysis, 2020-2021
             10.6.2. Global Recession Influence, 2020-2021
             10.6.3. Latin America Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
             10.6.4. Latin America Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
             10.6.5. Latin America Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
             10.6.6. Latin America Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
             10.6.7. Latin America Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
             10.6.8. Latin America Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
             10.6.9. Brazil
                       10.6.9.1. Brazil Biosurveillance Market estimates and forecast, 2019 – 2030, (USD Billion)
                       10.6.9.2. Brazil Biosurveillance Market estimates and forecast By Type, 2019 –2030, (USD Billion)
                       10.6.9.3. Brazil Biosurveillance Market estimates and forecast By Technology & equipment, 2019 –2030, (USD Billion)
                       10.6.9.4. Brazil Biosurveillance Market estimates and forecast By Application, 2019 –2030, (USD Billion)
                       10.6.9.5. Brazil Biosurveillance Market estimates and forecast By End-use,2019 –2030, (USD Billion)
                       10.6.9.6. Brazil Biosurveillance Market estimates and forecast By End-user,2019 –2030, (USD Billion)
Chapter 11. Competitive Landscape
    11.1. Market Revenue Share By Manufacturers
    11.2. Manufacturing Cost Breakdown Analysis
    11.3. Mergers & Acquisitions
    11.4. Market positioning
    11.5. Strategy Benchmarking
    11.6. Vendor Landscape
Chapter 12. Company Profiles
    12.1. Bitscopic
            12.1.1. Company Overview
            12.1.2. Financial Performance
            12.1.3. Technology Insights
            12.1.4. Strategic Initiatives
    12.2. Hawkeye Systems, Inc
            12.2.1. Company Overview
            12.2.2. Financial Performance
            12.2.3. Technology Insights
            12.2.4. Strategic Initiatives
    12.3. NanoViricides, Inc
            12.3.1. Company Overview
             12.3.2. Financial Performance
             12.3.3. Technology Insights
             12.3.4. Strategic Initiatives
    12.4. Co-Diagnostics, Inc..
           12.4.1. Company Overview
           12.4.2. Financial Performance
           12.4.3. Technology Insights
            12.4.4. Strategic Initiatives
    12.5. Gilead Sciences, Inc.
             12.5.1. Company Overview
             12.5.2. Financial Performance
             12.5.3. Technology Insights
             12.5.4. Strategic Initiatives
    12.6. Novavax, Inc.
            12.6.1. Company Overview
             12.6.2. Financial Performance
             12.6.3. Technology Insights
             12.6.4. Strategic Initiatives
    12.7. Dynport Vaccine Company LLC
              12.7.1. Company Overview
              12.7.2. Financial Performance
              12.7.3. Technology Insights
              12.7.4. Strategic Initiatives
    12.8. B.Ichor Medical Systems
            12.8.1. Company Overview
            12.8.2. Financial Performance
            12.8.3. Technology Insights
            12.8.4. Strategic Initiatives
    12.9. Bavarian Nordic
            12.9.1. Company Overview
            12.9.2. Financial Performance
            12.9.3. Technology Insights
            12.9.4. Strategic Initiatives
    12.10. Cleveland Biolabs
               12.10.1. Company Overview
               12.10.2. Financial Performance
               12.10.3. Technology Insights
               12.10.4. Strategic Initiatives

Delivery Format : EXCEL/Data Pack

Choose License Type

Checkout Inquiry Sample